Kriti Industries (India) Limited (NSE:KRITI)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	8,350	4,921	6,607	5,775	5,293	3,631
Market Cap Growth	-25.52%	-25.52%	14.41%	9.11%	45.77%	577.78%
Enterprise Value	9,353	6,064	7,605	6,776	5,838	4,043
Last Close Price	158.63	97.44	133.36	113.59	106.34	7.92
PE Ratio	-	-	30.13	-	26.55	10.07
PS Ratio	1.16	0.68	0.76	0.79	0.97	0.62
PB Ratio	4.14	2.44	4.36	4.44	3.43	2.70
P/TBV Ratio	4.14	2.44	4.36	4.44	3.44	2.70
P/FCF Ratio	317.84	187.32	36.10	-	-	17.76
P/OCF Ratio	24.73	14.57	11.31	21.54	131.39	12.30
EV/Sales Ratio	1.30	0.84	0.88	0.93	1.07	0.69
EV/EBITDA Ratio	33.32	21.67	12.79	-	14.68	5.84
EV/EBIT Ratio	68.63	43.74	16.02	-	18.38	6.56
EV/FCF Ratio	356.00	230.80	41.55	-	-	19.77
Debt / Equity Ratio	0.50	0.50	0.85	0.92	0.64	0.60
Debt / EBITDA Ratio	3.55	3.55	2.16	-	2.49	1.17
Debt / FCF Ratio	38.23	38.23	7.01	-	-	3.95
Asset Turnover	1.56	1.56	2.00	1.79	1.41	1.64
Inventory Turnover	3.56	3.56	4.39	3.55	2.39	3.01
Quick Ratio	0.28	0.28	0.35	0.27	0.15	0.21
Current Ratio	1.23	1.23	1.19	1.08	1.31	1.35
Return on Equity (ROE)	-2.42%	-2.42%	15.56%	-16.04%	9.90%	32.57%
Return on Assets (ROA)	1.87%	1.87%	6.86%	-2.57%	5.13%	10.73%
Return on Capital (ROIC)	2.98%	2.98%	11.20%	-4.20%	8.48%	19.67%
Return on Capital Employed (ROCE)	5.60%	5.60%	21.60%	-	16.70%	34.90%
Earnings Yield	-0.51%	-0.87%	3.32%	-3.98%	3.77%	9.93%
FCF Yield	0.31%	0.53%	2.77%	-0.55%	-2.60%	5.63%
Dividend Yield	-	-	0.15%	-	0.19%	2.53%
Payout Ratio	-	-	-	-	4.98%	2.06%
Buyback Yield / Dilution	-3.02%	-3.02%	-	-	-	-
Total Shareholder Return	-	-3.02%	0.15%	-	0.19%	2.53%

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.